CVE-2026-42933

critical

Published 2026-07-23 · Modified 2026-07-23

💬 Discuss on Community ✚ Propose mitigation

CVSS v3

10.0

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H

CVSS v4 NEW

10.0

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H

VIR risk

10.0

Description

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.

Predictions

Exploit likelihood

98%

Patch ETA

—

Heuristic predictions, AS-IS, for prioritization only.

Mitigations

No mitigations published for this CVE yet.

The vendor-content worker queues fetches as references arrive (check back in a few minutes). Or — if you've already worked around this in production — publish your fix to the community-verified tier.

✚ Propose a mitigation on Community → Mitigations published via the community go through AI scoring + 2 human reviewers + 7-day silent objection window before landing here with source_tier=community-verified.

References

https://www.cisa.gov/news-events/ics-advisories/icsa-26-204-04

CWEs

CWE-441

Community-verified mitigations for this CVE will appear above when contributors publish them.

Verify integrity in audit chain (admin only). AS-IS.